MAP3K7 and ovarian cancer: Further, when CXCL8 binds to CXCR1/2, it can activate transforming growth factor beta-activated kinase 1/Nuclear factor-kappa B (TAK1/NFκB) signaling and enhance the migration and invasiveness of ovarian cancer cells.